COMMUNIQUÉS West-GlobeNewswire

IntelGenx to Promote VetaFilm™ Oral Film Technology at Human Biotech & Animal Health Business Partnering Summit
08/04/2019
SAINT LAURENT, Quebec, April 08, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced that it will promote its proprietary VetaFilm™ oral [...]
Daré Bioscience Announces Publication of Pharmacokinetics Study of DARE-HRT1, a Potential Hormone Replacement Therapy, in the Journal of Pharmaceutical Sciences
08/04/2019
SAN DIEGO, April 08, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, today announced the article entitled “Pharmacokinetics and tolerability of a novel 17β-estradiol [...]
Opiant Pharmaceuticals Announces Publication of Clinical Pharmacokinetic Data Supporting Potential of OPNT003, Nasal Nalmefene, for Treatment of Synthetic Opioid Overdose
08/04/2019
Data published online in the Journal of Pharmacology and Experimental Therapeutics SANTA MONICA, Calif., April 08, 2019 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT), a specialty pharmaceutical company [...]
Kaleido Biosciences Announces Key Appointments to Leadership Team
08/04/2019
Johan van Hylckama Vlieg, Ph.D., Named Chief Scientific Officer and Clare Fisher Appointed Chief Business Officer LEXINGTON, Mass., April 08, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc . (Nasdaq: KLDO), a [...]
HealthLynked Announces the Addition of Richard Williamson as New VP of Marketing
08/04/2019
NAPLES, Fla., April 08, 2019 (GLOBE NEWSWIRE) -- HealthLynked Corp ( OTCQB: HLYK ) (the “Company”), a leader in digital healthcare technology, today announced the appointment of Richard Williamson as Vice President of [...]
Cue Biopharma to Present Immuno-STAT Platform Technology at PEGs Boston 2019
08/04/2019
CAMBRIDGE, Mass., April 08, 2019 (GLOBE NEWSWIRE) -- Cue Biopharma , Inc. (NASDAQ: CUE), an innovative immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the [...]
TYME’s SM-88 First Human Study in Patients with Metastatic Cancer Published in the Journal, Investigational New Drugs
08/04/2019
New oral approach aimed at disrupting cancer metabolism SM-88 is an investigational Cancer Metabolism-Based Therapy (CMBTs TM ) that has demonstrated responses across 15 different cancers 30 patients enrolled in study [...]
Profound Medical Analyst & Investor Day Agenda
08/04/2019
TORONTO, April 08, 2019 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which combine real-time Magnetic [...]
PDS Biotechnology Appoints Stephen Glover to its Board of Directors
08/04/2019
BERKELEY HEIGHTS, N.J., April 08, 2019 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immuno-oncology company developing novel multifunctional immunotherapeutic products, today [...]
PotNetwork News Signs on as Media Sponsor for Cannabis World Congress and Business Expo and CBD Expo Tour
08/04/2019
The industry's leader for marijuana news and information brings its successful live broadcasts to two of the top tradeshows in the entrepreneurial cannabis space MIAMI, April 08, 2019 (GLOBE NEWSWIRE) -- PotNetwork News [...]
MediPharm Labs Assembles Globally Renowned Experts to Form Scientific Advisory Committee
08/04/2019
TORONTO, April 08, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MLCPF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, [...]
Oncology Venture invites to a webcast April 8 at 16:30
08/04/2019
Investor News Following the presentation of Oncology Venture’s prospectus as part of the rights issue announced on Friday, April 5, the company invites to a webcast. At the webcast, Oncology Venture’s CEO Peter Buhl [...]
Melinta Therapeutics Announces Multiple Presentations at the 29th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
08/04/2019
~ Presentations and Posters Highlight New Data from Antibiotics Portfolio ~ MORRISTOWN, N.J., April 08, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company focused on the [...]
VitalHub Announces Licensing of Patient Flow Solution to Leading Middle East Hospital
08/04/2019
TORONTO, April 08, 2019 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased to announce that it has licensed its MCAP patient flow software solution to Hamad Medical Corporation (“HMC [...]
IMMUNOTHERAPY COMPANY ENLIVEX THERAPEUTICS COMPLETES PREVIOUSLY ANNOUNCED FINANCING PRICED AT $12.25 PER SHARE, RAISING A TOTAL OF APPROXIMATELY $8.4 MILLION
08/04/2019
Nes Ziona, Israel, April 08, 2019 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage immunotherapy company, today announced the final closing of a private placement financing of ordinary [...]
Translate Bio Appoints Richard Wooster as Chief Scientific Officer
08/04/2019
-- Appointment strengthens scientific leadership team and highlights the Company’s commitment to innovative mRNA research and development -- LEXINGTON, Mass., April 08, 2019 (GLOBE NEWSWIRE) -- Translate Bio, Inc. ( [...]
Nephros Announces Preliminary Financial Results for First Quarter 2019
08/04/2019
Anticipates $1.7 Million Revenue; Year-over-Year Growth Exceeds 75% SOUTH ORANGE, NJ, April 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device and commercial [...]
Todos and Amarantus Announce Completion of LymPro PET 1 Study by Leipzig University for Alzheimer’s Blood Diagnostic LymPro Test 2.0
08/04/2019
REHOVOT, Israel and NEW YORK, April 08, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection of [...]
American Cannabis Market Fueled By Positive Legislation
08/04/2019
SEATTLE, April 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an [...]

Pages